Struma ovarii pathophysiology: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Aravind Reddy Kothagadi (talk | contribs)
nocaptcha
4,243 edits
Mmir (talk | contribs)
CMEAdmin, CMEUser, Bureaucrats, bureaucrats, nocaptcha, smwadministrator, Administrators, Widget editors
14,850 edits
 
(33 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Struma ovarii}}
{{Struma ovarii}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{ARK}}
==Overview==
==Overview==
*The exact pathogenesis of [disease name] is not fully understood.
It is thought that struma ovarii is mediated by activation of the [[Mitogen-activated protein kinase|mitogen activated protein kinase]] signaling pathway as a critical step in [[tumorigenesis]]. Malignant struma ovarii (MSO) are rare tumors which arise from [[ectopic]] [[thyroid]] tissue in the ovary which is [[benign]]. The [[genes]] involved in the [[pathogenesis]] of malignant struma ovarii include [[BRAF]] (35% to 69%), [[RAS]] (10%), and [[RET gene|RET]] (5% to 30%).  On gross pathological examination, struma ovarii may be present as: [[Solid tumors|Solid]] and cystic tumor, tumor with several [[nodules]] partially separated by gray whitish [[fibrous tissue]], [[Nodule|nodules]] appear tan-brown in color with small dark red areas, [[Cystic]] spaces filled with yellow-brown or straw-colored fluid, and focal areas of [[calcification]]. Microscopic pathology of struma ovarii is similar to the thyroid tissue with cellular solid or cystic cluster of variable size with [[cuboidal]] or columnar morphology and [[Eosinophilic|eosinophilic cytoplasm]], round nuclei with finely granular [[chromatin]], and [[Colloid]] presentation.
OR
 
*It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
*The progression to [disease name] usually involves the [molecular pathway].
*The pathophysiology of [disease/malignancy] depends on the histological subtype.
==Pathophysiology==
==Pathophysiology==


===Pathogenesis===
===Pathogenesis===
*The exact pathogenesis of [disease name] is not fully understood.
* Struma ovarii is a type of monodermal highly specialized [[Teratoma|ovarian teratomas]], consist of mature [[thyroid]] tissue.  
OR
* It is thought that struma ovarii is mediated by activation of the [[Mitogen-activated protein kinase|mitogen activated protein kinase]] signaling pathway as a critical step in [[tumorigenesis]]. This process has been understood by molecular analysis of [[follicular cell]] derived [[Thyroid carcinoma|thyroid carcinomas]]. <ref name="pmid17721188">{{cite journal |vauthors=Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL, Nosé V |title=BRAF in papillary thyroid carcinoma of ovary (struma ovarii) |journal=Am. J. Surg. Pathol. |volume=31 |issue=9 |pages=1337–43 |year=2007 |pmid=17721188 |doi=10.1097/PAS.0b013e31802f5404 |url=}}</ref>
*It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
*Malignant struma ovarii (MSO) are rare [[tumors]] which arise from [[ectopic]] benign [[thyroid]] tissue in the ovary. Malignant transformation of struma ovarii is not common and occurs in less than 5% of all cases, and it is even rarer to lead to [[metastatic]] disease (5–6%). <ref name="pmid10366477">{{cite journal |vauthors=Dardik RB, Dardik M, Westra W, Montz FJ |title=Malignant struma ovarii: two case reports and a review of the literature |journal=Gynecol. Oncol. |volume=73 |issue=3 |pages=447–51 |year=1999 |pmid=10366477 |doi=10.1006/gyno.1999.5355 |url=}}</ref> <ref name="pmid27355004">{{cite journal |vauthors=Oudoux A, Leblanc E, Beaujot J, Gauthier-Kolesnikov H |title=Treatment and follow-up of malignant struma ovarii: Regarding two cases |journal=Gynecol Oncol Rep |volume=17 |issue= |pages=56–9 |year=2016 |pmid=27355004 |pmc=4913172 |doi=10.1016/j.gore.2016.05.014 |url=}}</ref>
*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
*In malignant struma ovarii (MSO), the cancer can spread to the contralateral [[ovary]]; also other sites such as abdominopelvic [[Lymph node|lymph nodes]], the [[peritoneal cavity]], [[lungs]], [[scalp]], [[brain]], [[diaphragm]], and [[liver]] may be involved. <ref name="pmid25474425">{{cite journal |vauthors=Luo JR, Xie CB, Li ZH |title=Treatment for malignant struma ovarii in the eyes of thyroid surgeons: a case report and study of Chinese cases reported in the literature |journal=Medicine (Baltimore) |volume=93 |issue=26 |pages=e147 |year=2014 |pmid=25474425 |pmc=4616397 |doi=10.1097/MD.0000000000000147 |url=}}</ref>
*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
*Routes of [[metastasis]] are: <ref name="pmid20119594">{{cite journal |vauthors=Yücesoy G, Cakiroglu Y, Muezzinoglu B, Besnili B, Yucesoy I |title=Malignant struma ovarii: a case report |journal=J. Korean Med. Sci. |volume=25 |issue=2 |pages=327–9 |year=2010 |pmid=20119594 |pmc=2811308 |doi=10.3346/jkms.2010.25.2.327 |url=}}</ref> <ref name="pmid2910784">{{cite journal |vauthors=Rosenblum NG, LiVolsi VA, Edmonds PR, Mikuta JJ |title=Malignant struma ovarii |journal=Gynecol. Oncol. |volume=32 |issue=2 |pages=224–7 |year=1989 |pmid=2910784 |doi= |url=}}</ref> <ref name="pmid11700816">{{cite journal |vauthors=Chan SW, Farrell KE |title=Metastatic thyroid carcinoma in the presence of struma ovarii |journal=Med. J. Aust. |volume=175 |issue=7 |pages=373–4 |year=2001 |pmid=11700816 |doi= |url=}}</ref>
*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
:*1) Regional [[lymphatics]] to [[pelvic]] and [[paraaortic lymph nodes]]
*The progression to [disease name] usually involves the [molecular pathway].
:*2) Direct spread to the [[omentum]], [[peritoneal cavity]] and the contralateral ovary
*The pathophysiology of [disease/malignancy] depends on the histological subtype.
:*3) [[Hematologic]] dissemination to the [[bone]], [[lung]], [[liver]] and [[brain]]
*Malignant struma ovarii manifest as [[Follicular carcinoma of the Thyroid|follicular carcinoma]] (causing [[peritoneal]] strumosis as a result of [[peritoneal]] spread), [[Papillary carcinoma of the thyroid|papillary carcinoma]] or follicular micro-carcinoma, a variant of [[Papillary carcinoma of the thyroid|papillary carcinoma]] (showing [[BRAF]] and [[RAS]] mutations) and rarely with [[Carcinoid syndrome|carcinoid]] and along with [[lymphoma]]. <ref name="pmid24783110">{{cite journal |vauthors=Sinha NK |title=Struma ovarii with elevated ca-125 levels and ascites mimicking advanced ca ovary |journal=J Clin Diagn Res |volume=8 |issue=3 |pages=140–1 |year=2014 |pmid=24783110 |pmc=4003614 |doi=10.7860/JCDR/2014/8005.4138 |url=}}</ref> <ref name="pmid19471561">{{cite journal |vauthors=Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS |title=Clinical characteristics of struma ovarii |journal=J Gynecol Oncol |volume=19 |issue=2 |pages=135–8 |year=2008 |pmid=19471561 |pmc=2676458 |doi=10.3802/jgo.2008.19.2.135 |url=}}</ref>


==Genetics==
==Genetics==
*[Disease name] is transmitted in [mode of genetic transmission] pattern.
*The [[genes]] involved in the [[pathogenesis]] of malignant struma ovarii include [[BRAF]] (35% to 69%), [[RAS]] (10%), and [[RET gene|RET]] (5% to 30%). <ref name="pmid17721188">{{cite journal |vauthors=Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL, Nosé V |title=BRAF in papillary thyroid carcinoma of ovary (struma ovarii) |journal=Am. J. Surg. Pathol. |volume=31 |issue=9 |pages=1337–43 |year=2007 |pmid=17721188 |doi=10.1097/PAS.0b013e31802f5404 |url=}}</ref>
*Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
*The development of malignant struma ovarii (MSO) along with [[Papillary thyroid carcinoma|papillary thyroid carcinomas]] (PTC) features is associated with mutations in the [[BRAF]] of the type which is commonly observed in [[PTC]], therefore it suggests a common [[pathogenesis]] for all PTCs regardless of their location. On the contrary, mutations in the [[RET gene|RET]]/[[RAS]]/RAF pathway are not observed  in BSO (Benign Struma ovarii). <ref name="pmid17721188">{{cite journal |vauthors=Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL, Nosé V |title=BRAF in papillary thyroid carcinoma of ovary (struma ovarii) |journal=Am. J. Surg. Pathol. |volume=31 |issue=9 |pages=1337–43 |year=2007 |pmid=17721188 |doi=10.1097/PAS.0b013e31802f5404 |url=}}</ref>
*The development of [disease name] is the result of multiple genetic mutations.
 
==Associated Conditions==
==Associated Conditions==
*Adenomatous or colloid cervical goiters. <ref name="pmid5448747">{{cite journal |vauthors=Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG |title=Struma ovarii--ascitic, hyperthyroid, and asymptomatic syndromes |journal=Ann. Intern. Med. |volume=72 |issue=6 |pages=883–93 |year=1970 |pmid=5448747 |doi= |url=}}</ref>
The most important extra-ovaries associated conditions with stroma ovarri include:
*Hyperthyroidism in postmenopausal woman. <ref name="pmid19955234">{{cite journal |vauthors=Nonne N, Ameyar-Zazoua M, Souidi M, Harel-Bellan A |title=Tandem affinity purification of miRNA target mRNAs (TAP-Tar) |journal=Nucleic Acids Res. |volume=38 |issue=4 |pages=e20 |year=2010 |pmid=19955234 |pmc=2831319 |doi=10.1093/nar/gkp1100 |url=}}</ref>
*[[Adenomatous]] or colloid cervical goiters <ref name="pmid5448747">{{cite journal |vauthors=Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG |title=Struma ovarii--ascitic, hyperthyroid, and asymptomatic syndromes |journal=Ann. Intern. Med. |volume=72 |issue=6 |pages=883–93 |year=1970 |pmid=5448747 |doi= |url=}}</ref>
*[[Hyperthyroidism]] in [[postmenopausal]] woman <ref name="pmid19955234">{{cite journal |vauthors=Nonne N, Ameyar-Zazoua M, Souidi M, Harel-Bellan A |title=Tandem affinity purification of miRNA target mRNAs (TAP-Tar) |journal=Nucleic Acids Res. |volume=38 |issue=4 |pages=e20 |year=2010 |pmid=19955234 |pmc=2831319 |doi=10.1093/nar/gkp1100 |url=}}</ref>
*Pseudo-Meig's syndrome <ref name="pmid22436494">{{cite journal |vauthors=Mostaghel N, Enzevaei A, Zare K, Fallahian M |title=Struma ovarii associated with Pseudo-Meig's syndrome and high serum level of CA 125; a case report |journal=J Ovarian Res |volume=5 |issue= |pages=10 |year=2012 |pmid=22436494 |pmc=3350392 |doi=10.1186/1757-2215-5-10 |url=}}</ref>
*Pseudo-Meig's syndrome <ref name="pmid22436494">{{cite journal |vauthors=Mostaghel N, Enzevaei A, Zare K, Fallahian M |title=Struma ovarii associated with Pseudo-Meig's syndrome and high serum level of CA 125; a case report |journal=J Ovarian Res |volume=5 |issue= |pages=10 |year=2012 |pmid=22436494 |pmc=3350392 |doi=10.1186/1757-2215-5-10 |url=}}</ref>
*Hashimoto's thyroiditis <ref name="pmid17276434">{{cite journal |vauthors=Morrissey K, Winkel C, Hild S, Premkumar A, Stratton P |title=Struma ovarii coincident with Hashimoto's thyroiditis: an unusual cause of hyperthyroidism |journal=Fertil. Steril. |volume=88 |issue=2 |pages=497.e15–7 |year=2007 |pmid=17276434 |pmc=2753978 |doi=10.1016/j.fertnstert.2006.11.095 |url=}}</ref>
*[[Hashimoto's thyroiditis]] <ref name="pmid17276434">{{cite journal |vauthors=Morrissey K, Winkel C, Hild S, Premkumar A, Stratton P |title=Struma ovarii coincident with Hashimoto's thyroiditis: an unusual cause of hyperthyroidism |journal=Fertil. Steril. |volume=88 |issue=2 |pages=497.e15–7 |year=2007 |pmid=17276434 |pmc=2753978 |doi=10.1016/j.fertnstert.2006.11.095 |url=}}</ref>
*Thyrotoxicosis <ref name="pmid17276434">{{cite journal |vauthors=Morrissey K, Winkel C, Hild S, Premkumar A, Stratton P |title=Struma ovarii coincident with Hashimoto's thyroiditis: an unusual cause of hyperthyroidism |journal=Fertil. Steril. |volume=88 |issue=2 |pages=497.e15–7 |year=2007 |pmid=17276434 |pmc=2753978 |doi=10.1016/j.fertnstert.2006.11.095 |url=}}</ref>
*[[Thyrotoxicosis]] <ref name="pmid17276434">{{cite journal |vauthors=Morrissey K, Winkel C, Hild S, Premkumar A, Stratton P |title=Struma ovarii coincident with Hashimoto's thyroiditis: an unusual cause of hyperthyroidism |journal=Fertil. Steril. |volume=88 |issue=2 |pages=497.e15–7 |year=2007 |pmid=17276434 |pmc=2753978 |doi=10.1016/j.fertnstert.2006.11.095 |url=}}</ref>
*[[Peritoneal]] strumosis which are [[benign]] lesions<ref name="ButtWantenaar2016">{{cite journal|last1=Butt|first1=Jennifer L|last2=Wantenaar|first2=Tanya I|title=The diagnosis and management of struma ovarii|journal=Southern African Journal of Gynaecological Oncology|volume=8|issue=1|year=2016|pages=24–26|issn=2074-2835|doi=10.1080/20742835.2016.1180776}}</ref>
Struma ovarii can be seen associated with other ovarian diseases include: <ref name="pmid24357453">{{cite journal |vauthors=Dujardin MI, Sekhri P, Turnbull LW |title=Struma ovarii: role of imaging? |journal=Insights Imaging |volume=5 |issue=1 |pages=41–51 |year=2014 |pmid=24357453 |pmc=3948908 |doi=10.1007/s13244-013-0303-3 |url=}}</ref>
* Ovarian mature cystic [[teratoma]]
* Ovarian [[cystadenoma|serous cystadenoma]]
* Ovarian [[mucinous cystadenoma]]
* [[Brenner tumor|Brenner's tumor]] of ovary
* [[Carcinoid tumor]]


==Gross Pathology==
==Gross Pathology==
*On gross pathological examination, Struma ovarii characteristically presents as a: <ref name="pmid3563194">{{cite journal |vauthors=Piérard GE, Piérard-Franchimont C |title=[Acute and chronic borrelioses transmitted by ticks along the Meuse River and in bordering regions] |language=French |journal=Rev Med Liege |volume=42 |issue=3 |pages=101–6 |year=1987 |pmid=3563194 |doi= |url=}}</ref> <ref name="pmid2753978">{{cite journal |vauthors=Gaitan E, Cooksey RC, Meydrech EF, Legan J, Gaitan GS, Astudillo J, Guzman R, Guzman N, Medina P |title=Thyroid function in neonates from goitrous and nongoitrous iodine-sufficient areas |journal=J. Clin. Endocrinol. Metab. |volume=69 |issue=2 |pages=359–63 |year=1989 |pmid=2753978 |doi=10.1210/jcem-69-2-359 |url=}}</ref>
On gross pathological examination, struma ovarii may be present as: <ref name="pmid3563194">{{cite journal |vauthors=Piérard GE, Piérard-Franchimont C |title=[Acute and chronic borrelioses transmitted by ticks along the Meuse River and in bordering regions] |language=French |journal=Rev Med Liege |volume=42 |issue=3 |pages=101–6 |year=1987 |pmid=3563194 |doi= |url=}}</ref> <ref name="pmid2753978">{{cite journal |vauthors=Gaitan E, Cooksey RC, Meydrech EF, Legan J, Gaitan GS, Astudillo J, Guzman R, Guzman N, Medina P |title=Thyroid function in neonates from goitrous and nongoitrous iodine-sufficient areas |journal=J. Clin. Endocrinol. Metab. |volume=69 |issue=2 |pages=359–63 |year=1989 |pmid=2753978 |doi=10.1210/jcem-69-2-359 |url=}}</ref>
:*Solid and cystic tumor.
* [[Solid tumors|Solid]] and cystic tumor
:*Tumor with several nodules partially separated by gray whitish fibrous tissue.
* Tumor with several [[nodules]] partially separated by gray whitish [[fibrous tissue]]
:*Nodules appear tan-brown in color with small dark red areas.
* [[Nodule|Nodules]] appear tan-brown in color with small dark red areas
:*Cystic spaces filled with yellow-brown or straw-colored fluid.
* [[Cystic]] spaces filled with yellow-brown or straw-colored fluid
:*Focal areas of calcification are observed.
* Focal areas of [[calcification]]


==Microscopic Pathology==
==Microscopic Pathology==
*On microscopic histopathological analysis the tumor was initially diagnosed as granulosa cell tumor in frozen study but finally turned out to be Struma Ovarii which is the characteristic finding of Struma ovarii. <ref name="pmid22436494">{{cite journal |vauthors=Mostaghel N, Enzevaei A, Zare K, Fallahian M |title=Struma ovarii associated with Pseudo-Meig's syndrome and high serum level of CA 125; a case report |journal=J Ovarian Res |volume=5 |issue= |pages=10 |year=2012 |pmid=22436494 |pmc=3350392 |doi=10.1186/1757-2215-5-10 |url=}}</ref>
Microscopic pathology of struma ovarii is similar to the thyroid tissue:
*Hematoxylin and eosin-stained tissue helps analyze branching papillae with atypical cytologic features including nuclear groves, clearing, overlapping, and enlargement, consistent with papillary thyroid carcinoma arising in a struma ovarii. <ref name="pmid22315711">{{cite journal |vauthors=Alvarez DM, Lee V, Bhatt S, Dogra VS |title=Struma ovarii with papillary thyroid carcinoma |journal=J Clin Imaging Sci |volume=1 |issue= |pages=44 |year=2011 |pmid=22315711 |pmc=3272908 |doi=10.4103/2156-7514.84322 |url=}}</ref>
*Cellular solid or cystic cluster of variable size with [[cuboidal]] or columnar morphology and [[Eosinophilic|eosinophilic cytoplasm]]
*Round nuclei with finely granular [[chromatin]]
*[[Colloid]] is seen
May develop pathologies seen in the [[thyroid gland]]; for instance [[Papillary thyroid carcinoma (PTC)|papillary thyroid carcinoma]] in a struma ovarii can be recognized in [[Hematoxylin and eosin stain|hematoxylin and eosin-stained]] tissue with branching papillae with [[Atypia|atypical malignant cytologic]] features including nuclear groves, overlapping, and enlargement. <ref name="pmid22315711">{{cite journal |vauthors=Alvarez DM, Lee V, Bhatt S, Dogra VS |title=Struma ovarii with papillary thyroid carcinoma |journal=J Clin Imaging Sci |volume=1 |issue= |pages=44 |year=2011 |pmid=22315711 |pmc=3272908 |doi=10.4103/2156-7514.84322 |url=}}</ref>
[[image:Struma ovarii.jpg|thumb|500px|center|By Nephron - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=16068779]]


[[File:Struma_ovarii_Microscopic_appearance_of_the_resected_tumor.jpg|thumb|none|450px| Microscopic appearance of the resected tumor. <ref name="pmid22436494">{{cite journal |vauthors=Mostaghel N, Enzevaei A, Zare K, Fallahian M |title=Struma ovarii associated with Pseudo-Meig's syndrome and high serum level of CA 125; a case report |journal=J Ovarian Res |volume=5 |issue= |pages=10 |year=2012 |pmid=22436494 |pmc=3350392 |doi=10.1186/1757-2215-5-10 |url=}}</ref> ]]


[[File:Struma_ovarii_H&E.jpg|thumb|none|450px| Hematoxylin and eosin-stained tissue (400×) displaying branching papillae with atypical cytologic features including nuclear groves, clearing, overlapping, and enlargement, consistent with papillary thyroid carcinoma arising in a struma ovarii. <ref name="pmid22315711">{{cite journal |vauthors=Alvarez DM, Lee V, Bhatt S, Dogra VS |title=Struma ovarii with papillary thyroid carcinoma |journal=J Clin Imaging Sci |volume=1 |issue= |pages=44 |year=2011 |pmid=22315711 |pmc=3272908 |doi=10.4103/2156-7514.84322 |url=}}</ref> ]]
[[image:Thyroid papillary carcinoma histopathology .jpg|thumb|500px|center|CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=502859]]


==References==
==References==

Latest revision as of 00:09, 16 October 2017

Struma ovarii Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Struma ovarii from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Struma ovarii pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Struma ovarii pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Struma ovarii pathophysiology

CDC on Struma ovarii pathophysiology

Struma ovarii pathophysiology in the news

Blogs on Struma ovarii pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Struma ovarii pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

Overview

It is thought that struma ovarii is mediated by activation of the mitogen activated protein kinase signaling pathway as a critical step in tumorigenesis. Malignant struma ovarii (MSO) are rare tumors which arise from ectopic thyroid tissue in the ovary which is benign. The genes involved in the pathogenesis of malignant struma ovarii include BRAF (35% to 69%), RAS (10%), and RET (5% to 30%). On gross pathological examination, struma ovarii may be present as: Solid and cystic tumor, tumor with several nodules partially separated by gray whitish fibrous tissue, nodules appear tan-brown in color with small dark red areas, Cystic spaces filled with yellow-brown or straw-colored fluid, and focal areas of calcification. Microscopic pathology of struma ovarii is similar to the thyroid tissue with cellular solid or cystic cluster of variable size with cuboidal or columnar morphology and eosinophilic cytoplasm, round nuclei with finely granular chromatin, and Colloid presentation.

Pathophysiology

Pathogenesis

Genetics

  • The genes involved in the pathogenesis of malignant struma ovarii include BRAF (35% to 69%), RAS (10%), and RET (5% to 30%). [1]
  • The development of malignant struma ovarii (MSO) along with papillary thyroid carcinomas (PTC) features is associated with mutations in the BRAF of the type which is commonly observed in PTC, therefore it suggests a common pathogenesis for all PTCs regardless of their location. On the contrary, mutations in the RET/RAS/RAF pathway are not observed in BSO (Benign Struma ovarii). [1]

Associated Conditions

The most important extra-ovaries associated conditions with stroma ovarri include:

Struma ovarii can be seen associated with other ovarian diseases include: [15]

Gross Pathology

On gross pathological examination, struma ovarii may be present as: [16] [17]

Microscopic Pathology

Microscopic pathology of struma ovarii is similar to the thyroid tissue:

May develop pathologies seen in the thyroid gland; for instance papillary thyroid carcinoma in a struma ovarii can be recognized in hematoxylin and eosin-stained tissue with branching papillae with atypical malignant cytologic features including nuclear groves, overlapping, and enlargement. [18]

By Nephron - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=16068779


CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=502859

References

  1. ↑ 1.0 1.1 1.2 Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL, Nosé V (2007). "BRAF in papillary thyroid carcinoma of ovary (struma ovarii)". Am. J. Surg. Pathol. 31 (9): 1337–43. doi:10.1097/PAS.0b013e31802f5404. PMID 17721188.
  2. ↑ Dardik RB, Dardik M, Westra W, Montz FJ (1999). "Malignant struma ovarii: two case reports and a review of the literature". Gynecol. Oncol. 73 (3): 447–51. doi:10.1006/gyno.1999.5355. PMID 10366477.
  3. ↑ Oudoux A, Leblanc E, Beaujot J, Gauthier-Kolesnikov H (2016). "Treatment and follow-up of malignant struma ovarii: Regarding two cases". Gynecol Oncol Rep. 17: 56–9. doi:10.1016/j.gore.2016.05.014. PMC 4913172. PMID 27355004.
  4. ↑ Luo JR, Xie CB, Li ZH (2014). "Treatment for malignant struma ovarii in the eyes of thyroid surgeons: a case report and study of Chinese cases reported in the literature". Medicine (Baltimore). 93 (26): e147. doi:10.1097/MD.0000000000000147. PMC 4616397. PMID 25474425.
  5. ↑ Yücesoy G, Cakiroglu Y, Muezzinoglu B, Besnili B, Yucesoy I (2010). "Malignant struma ovarii: a case report". J. Korean Med. Sci. 25 (2): 327–9. doi:10.3346/jkms.2010.25.2.327. PMC 2811308. PMID 20119594.
  6. ↑ Rosenblum NG, LiVolsi VA, Edmonds PR, Mikuta JJ (1989). "Malignant struma ovarii". Gynecol. Oncol. 32 (2): 224–7. PMID 2910784.
  7. ↑ Chan SW, Farrell KE (2001). "Metastatic thyroid carcinoma in the presence of struma ovarii". Med. J. Aust. 175 (7): 373–4. PMID 11700816.
  8. ↑ Sinha NK (2014). "Struma ovarii with elevated ca-125 levels and ascites mimicking advanced ca ovary". J Clin Diagn Res. 8 (3): 140–1. doi:10.7860/JCDR/2014/8005.4138. PMC 4003614. PMID 24783110.
  9. ↑ Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS (2008). "Clinical characteristics of struma ovarii". J Gynecol Oncol. 19 (2): 135–8. doi:10.3802/jgo.2008.19.2.135. PMC 2676458. PMID 19471561.
  10. ↑ Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG (1970). "Struma ovarii--ascitic, hyperthyroid, and asymptomatic syndromes". Ann. Intern. Med. 72 (6): 883–93. PMID 5448747.
  11. ↑ Nonne N, Ameyar-Zazoua M, Souidi M, Harel-Bellan A (2010). "Tandem affinity purification of miRNA target mRNAs (TAP-Tar)". Nucleic Acids Res. 38 (4): e20. doi:10.1093/nar/gkp1100. PMC 2831319. PMID 19955234.
  12. ↑ Mostaghel N, Enzevaei A, Zare K, Fallahian M (2012). "Struma ovarii associated with Pseudo-Meig's syndrome and high serum level of CA 125; a case report". J Ovarian Res. 5: 10. doi:10.1186/1757-2215-5-10. PMC 3350392. PMID 22436494.
  13. ↑ 13.0 13.1 Morrissey K, Winkel C, Hild S, Premkumar A, Stratton P (2007). "Struma ovarii coincident with Hashimoto's thyroiditis: an unusual cause of hyperthyroidism". Fertil. Steril. 88 (2): 497.e15–7. doi:10.1016/j.fertnstert.2006.11.095. PMC 2753978. PMID 17276434.
  14. ↑ Butt, Jennifer L; Wantenaar, Tanya I (2016). "The diagnosis and management of struma ovarii". Southern African Journal of Gynaecological Oncology. 8 (1): 24–26. doi:10.1080/20742835.2016.1180776. ISSN 2074-2835.
  15. ↑ Dujardin MI, Sekhri P, Turnbull LW (2014). "Struma ovarii: role of imaging?". Insights Imaging. 5 (1): 41–51. doi:10.1007/s13244-013-0303-3. PMC 3948908. PMID 24357453.
  16. ↑ Piérard GE, Piérard-Franchimont C (1987). "[Acute and chronic borrelioses transmitted by ticks along the Meuse River and in bordering regions]". Rev Med Liege (in French). 42 (3): 101–6. PMID 3563194.
  17. ↑ Gaitan E, Cooksey RC, Meydrech EF, Legan J, Gaitan GS, Astudillo J, Guzman R, Guzman N, Medina P (1989). "Thyroid function in neonates from goitrous and nongoitrous iodine-sufficient areas". J. Clin. Endocrinol. Metab. 69 (2): 359–63. doi:10.1210/jcem-69-2-359. PMID 2753978.
  18. ↑ Alvarez DM, Lee V, Bhatt S, Dogra VS (2011). "Struma ovarii with papillary thyroid carcinoma". J Clin Imaging Sci. 1: 44. doi:10.4103/2156-7514.84322. PMC 3272908. PMID 22315711.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Struma_ovarii_pathophysiology&oldid=1374567"